We partner and network with the group of Dr. Marcus Menger from the Fraunhofer-Institute of Cell Therapies and Immunology to build a national competence center for aptamer research and development. Dr. Menger has broad experiences in the semi-automation of aptamer selection and applications.

We have Prof. Dr. Michael Famulok as one of CARD’s valued scientific advisers. He pioneered the aptamer R&D and established the SELEX technology in Europe.

We are collaborating with the Clickmer Systems GmbH, which is specialized in the generation of clickmers.